Express report: for pharmacy ordering officer orders for the 3RD and 4TH quarters of FY17
Ended Awarded
- Contract number
- 36C24718K0212
- Awardee
-
Lundbeck LLC UEI F1M3L99R99B3
- Awarding agency
-
Veterans Integrated Service Network 7
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $106,234
Award facts
- Contract value 100% obligated
- $106,234.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Deerfield, IL 60015, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Lundbeck LLC, a global pharmaceutical company. The contract is for the provision of various pharmaceutical products used to treat neurological conditions common to the veteran population, including Sabril (vigabatrin) for treatment-resistant seizures, Xenazine (tetrabenazine) for chorea associated with Huntington's disease, and Northera (droxidopa) for neurogenic orthostatic hypotension. The potential value of this specific call is $106,234.09. Lundbeck LLC holds a larger five-year Federal Supply Schedule (FSS) contract with the VA worth up to $124 million for pharmaceuticals and drugs, as well as a $31.5 million BPA for these specialized medications. There was no set-aside designation for this order.
Quick answers
Who was awarded contract 36C24718K0212?
36C24718K0212 was awarded to Lundbeck LLC by Veterans Integrated Service Network 7 (Veterans Health Administration) on April 1, 2017.
How much is contract 36C24718K0212 worth?
The government has obligated $106,234 on 36C24718K0212.
Is contract 36C24718K0212 an order under another contract?
Yes. 36C24718K0212 is a BPA call under V797D30249-VA797P14A0003, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24718K0212 competed?
The extent of competition for 36C24718K0212 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award